Abstract
A voltammetric study of the oxidation of Ceftazidime (CEFT) has been carried out at the glassy carbon electrode by cyclic, differential pulse (DPV) and square wave (SWV) voltammetry. The oxidation of CEFT was irreversible and exhibited diffusion controlled process depending on pH. The oxidation mechanism was proposed and discussed. According to the linear relationship between the peak current and concentration, DPV and SWV voltammetric methods for CEFT assay in pharmaceutical dosage forms and human urine were developed. For analytical purposes, a well resolved diffusion controlled voltammetric peak was obtained in 0.1 M H2SO4 at 1.00 and 1.02 V for differential pulse and square wave voltammetric techniques, respectively. The linear response was obtained within the range of 4 × 10−6−8 × 10−5 M with a detection limit of 6 × 10−7 M for differential pulse and 4 × 10−6–2 × 10−4 M with a detection limit of 1 × 10−6 M for square wave voltammetric technique. The determination of CEFT in 0.1 M H2SO4 was possible over the 2 × 10−6–1 × 10−4 M range in urine sample for both techniques. The standard addition method was used for the recovery studies.
Similar content being viewed by others
References
Hiremath, B., Mathada, B.H., and Mruthyunjayaswamy, Acta Pharmaceut., 2003, vol. 58, no. 3, p. 275.
Saleh, G.A., Askal, H.F., Refaat, I.H., and Mohmed, N.A., STP Pharma Sciences, 2002, vol. 12, no. 2, p. 133.
Saleh, G.A., Askal, H.F., Radwan, M.F., and Omar, M.A., Talanta, 2001, vol. 54, no. 6, p. 1205.
El-Walily, A.F.M., Gazy, A.A.K., Belal, S.F., and Khamis, E.F., Spectrosc. Lett., 2000, vol. 33, no. 6, p. 931.
Salem, H. and Askal, H., J. Pharm. Biomed. Anal., 2002, vol. 29, nos. 1–2, p. 347.
Ye, G.M., Cai, X.J., Wang, B., Zhou, Z.X., Yu, X.H., Wang, W.B., Zhang, J.D., Wang, Y.H., Dong, J.R., and Jiang, Y.Y., J. Pharm. Biomed. Anal., 2008, vol. 48, no. 3, p. 860.
Moreno, A.D. and Salgado, H.R.N., J. AOAC Intern., 2008, vol. 91, no. 4, p. 739.
Arzuaga, A., Maynar, J., Gascon, A.R., Solinis, M.A., Corral, E., and Pedraz, J.L. J. Pharm. Biomed. Anal., 2005, vol. 39, no. 5, p. 996.
Xu, W., Gao, P., Zhang, X.H., and Song, L., New Microbiologica, 2008, vol. 31, no. 3, p. 377.
Wang, R., Chen, L.R., Jia, Z.P., Xie, J.W., Hu, X.L., and Li, Y.M., Chin. J. Anal. Chem., 2002, vol. 30, no. 9, p. 1070.
Deby-Dupont, G., Deby, C., Mouithys-Mickalad, A., Hoebeke, M., Mathy-Hartert, M., Jadoul, L., Vandenberghe, A., and Lamy, M., Biochimica Et Biophysica Acta-General Subjects, 1998, vol. 1379, no. 1, p. 61.
El-Maali, N.A., Osman, A.H., Aly, A.A.M., and Al-Hazmi, G.A.A. Bioelectrochem., 2005, vol. 65, no. 2, p. 95.
Ferreira, V.S., Zanoni, M.V.B., Furlan, M., and Fogg, A.G., Anal. Chim. Acta, 1997, vol. 351, no. 1, p. 105.
Ferreiraa, V.S., Valnice, M., Zanonia, B.A., and Fogg, G., Microchem. J., 1997, vol. 57, no. 1, p. 115.
Dogan, B., Uslu, B., and Ozkan, S., Anal. Chem., 2008, vol. 80, no. 1, p. 209.
Ozkan, S.A., Uslu, B., and Aboul-Enein, H., Talanta, 2003, vol. 61, no. 2, p. 147.
Ozkan, S.A., Uslu, B., and Aboul-Enein, H., Crit. Rev. Anal. Chem., 2003, vol. 33, no. 3, p. 155.
Uslu, B. and Ozkan, S.A., Anal. Lett., 2007, vol. 40, no. 4, p. 1177.
Uslu, B. and Ozkan, S.A., Comb. Chem. High Throughput Screen, 2007, vol. 10, no. 7, p. 495
Electroanalytical Chemistry, 3rd Ed. / Ed. Wang, J., New York: Wiley-VCH Pub., 2008.
Kissinger, P.T. and Heineman, W.R., Laboratory Techniques in Electroanalytical Chemistry, 2nd Ed., New York: Marcel Dekker, 1996.
Golcu, A. and Ozkan, S.A., Pharmazie, 2006, vol. 61, no. 9, p. 760.
Analytical method development and validation / Eds. Swartz, M.E. and Krull, I., New York: Marcel Dekker, 1997.
Development and validation of analytical methods / Eds. Riley, C.M. and Rosanske, T.W., New York: Elsevier Science Ltd., 1996.
Method validation in pharmaceutical analysis, 1st Ed. / Eds. Ermer, J. and Miller McB., J.H., Germany: Wiley-VCH Pub., 2005.
Validation in chemical measurements / Eds. Bievre, P. D. and Günzler, H., Berlin: Springer Pub., 2005.
Validation of active pharmaceutical ingredients, 2nd Ed. / Eds. Berry, I.R. and Harpaz, D., Washington: CRC Press, 2001.
Dogan, B., Golcu, A., Dolaz, M., and Ozkan, S., Curr. Pharm. Anal., 2009, vol. 5, no. 2, p. 179.
Dogan, B., Golcu, A., Dolaz, M., and Ozkan, S., Curr. Pharm. Anal., 2009, vol. 5, no. 2, p. 197.
Golcu, A., Dogan, B., and Ozkan, S., Talanta, 2005, vol. 67, no. 4, p. 703.
Laviron, E., Roullier, L., and Degrand, C., J. Electroanal. Chem., 1980, vol. 112, no. 1, p. 11.
Bonnier, J.M., Amaud, R., and Maurey-Mey, M., Compt. Rend. Acad. Sci. (Paris), 1968, vol. C-267, p. 10.
Author information
Authors and Affiliations
Corresponding author
Additional information
The article is published in the original.
Rights and permissions
About this article
Cite this article
Tarinc, D., Dogan-Topal, B., Golcu, A. et al. Electrochemical investigation and determination of ceftazidime in pharmaceutical dosage forms and human urine. J Anal Chem 69, 899–908 (2014). https://doi.org/10.1134/S1061934814090056
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S1061934814090056